Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Application site erythema
ADR ID BADD_A00308
ADR Hierarchy
08      General disorders and administration site conditions
08.02      Administration site reactions
08.02.01      Application and instillation site reactions
08.02.01.001      Application site erythema
12      Injury, poisoning and procedural complications
12.07      Administration site reactions
12.07.01      Application and instillation site reactions
12.07.01.001      Application site erythema
23      Skin and subcutaneous tissue disorders
23.03      Epidermal and dermal conditions
23.03.06      Erythemas
23.03.06.005      Application site erythema
Description Not Available
MedDRA Code 10003041
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Application site erythema | Application site redness
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01230Ketoconazole0.000066%
BADD_D01251Latanoprost--
BADD_D01285Levothyroxine0.000019%
BADD_D01287Lidocaine0.000410%
BADD_D01317Loratadine0.000032%
BADD_D01359Mechlorethamine0.014987%
BADD_D01431Methylphenidate0.005674%
BADD_D01491Mometasone furoate--
BADD_D01517Naftifine0.003757%
BADD_D01564Nicotine0.016925%
BADD_D01579Nitroglycerin0.000548%
BADD_D01643Oxybutynin0.001468%
BADD_D01773Pimecrolimus--
BADD_D01867Propranolol0.000118%
BADD_D01955Rivastigmine0.013874%
BADD_D01956Rivastigmine tartrate--
BADD_D01973Rotigotine0.017537%
BADD_D01980Salicylic acid--
BADD_D01994Scopolamine0.003226%
BADD_D02002Selegiline0.157309%
BADD_D02065Spinosad--
BADD_D02105Tacrolimus--
BADD_D02119Tavaborole0.002340%
BADD_D02120Tazarotene0.010965%
BADD_D02160Terbinafine0.000298%
BADD_D02170Testosterone0.003399%
BADD_D02172Testosterone enanthate--
BADD_D02173Testosterone propionate--
BADD_D02174Testosterone undecanoate--
BADD_D02270Tretinoin0.000598%
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages